Loading...
XSHG
603363
Market cap1.13bUSD
Oct 09, Last price  
2.84CNY
1D
2.16%
1Q
-3.40%
IPO
-51.36%
Name

Fujian Aonong Biological Technology Group Incorporation Ltd

Chart & performance

D1W1MN
XSHG:603363 chart
P/E
99.92
P/S
0.92
EPS
0.03
Div yield, %
—
Shrs. gr., 5y
32.66%
Rev. gr., 5y
-5.95%
Revenues
8.47b
-3.29%
2,953,809,5214,184,442,7044,012,709,1174,978,470,5974,902,660,0975,761,891,9475,788,080,06611,517,165,75718,038,160,16021,613,039,52119,457,641,1308,762,672,7698,474,746,757
Net income
78m
-86.60%
24,991,36442,745,07433,776,94291,375,510108,118,87430,125,65729,155,735572,989,301-1,519,871,690-1,038,366,498-3,650,822,221579,345,02877,621,595
CFO
153m
P
137,262,6040129,237,958128,952,36826,775,90027,261,152394,159,196406,022,923524,291,286663,636,691984,006,832-116,781,234152,943,412
Dividend
Jun 08, 20210.15 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Fujian Aonong Biological Technology Group Incorporation Limited operates across diverse sectors, including animal feed production, swine farming, agricultural raw material trading, digital agricultural platforms, and bio-pharmaceuticals, serving both domestic Chinese and international markets. Its activities encompass the research, development, manufacturing, and distribution of various animal feed products, including specialized formulations for pigs, poultry, aquatic species, and ruminants. Furthermore, the company manages pig breeding facilities and is involved in the processing and slaughtering of swine. Aonong Biological Technology also supplies a range of veterinary products, such as vaccines, medicinal preparations, micro-ecological agents, powdered supplements, premixes, liquid oral treatments, feed additives, and disinfectants. Additionally, it develops and maintains an intelligent platform designed to support breeding services. Established in Xiamen, China, the company commenced operations in 2011.

Key people

Mingcheng Su
Chairman of the Board · since 2025
Youlin Wu
Vice Chairman of the Board, General Manager · since 2025
Shaoyong Hu
Deputy General Manager · since 2024
Bingchun Jiang
Deputy General Manager · since 2024
Qiang Lin
Deputy General Manager · since 2024
Zhou Yang
Chief Financial Officer, Deputy General Manager · since 2025
Jiang Peng
Deputy General Manager, Secretary of the Board · since 2024
Jiangfu Cai
Director · since 2024
Mingyi Chen
Director · since 2025
Haozhe Li
Director · since 2025
Jinglong Li
Director · since 2025
Independent Director · since 2021
Independent Director · since 2025
Daojin Yu
Independent Director · since 2025
Luying Zheng
Independent Director · since 2021
IPO date
Sep 26, 2017
Employees
Domiciled in
CN
Incorporated in
CN
Headquarters & legal address
福建省漳州市芗城区金峰经济开发区兴亭路与宝莲路交叉处
漳州市, FJ 350000
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT